<DOC>
	<DOCNO>NCT03059706</DOCNO>
	<brief_summary>This study evaluate efficacy intra-articular administration RegenoGel-OSP™ treat pain safety efficacy subject 's activity quality life follow arthroscopic surgery due degenerative traumatic meniscal tear . adult subject randomize sequentially assign RegenoGel-OSP™ placebo treatment 1:1 basis .</brief_summary>
	<brief_title>The Effect Intra-Articular Injection RegenoGel-OSP™ ( Self-Plasma ) Treat Pain Following Arthroscopic Surgery</brief_title>
	<detailed_description />
	<criteria>Subject sign date informed consent form . Subject male female age 45 . Patients schedule knee arthroscopic surgery due degenerative traumatic meniscal tear . Subject intraarticular injection intend study knee within 3 month prior Screening . Subject unable stop chronic administration pain medication ( include paracetamol ) , day study visit completion study visit . Subject history Psoriatic Arthritis , Rheumatoid Arthritis , inflammatory condition associate arthritis . Subject superficial wound area intend study knee . Subject schedule knee ligament reconstructive surgery . Subject fever sign symptoms systemic infection infection intend study knee . Subject known sensitivity treatment component , egg , rubber latex . Subject history anaphylactic shock severe systemic response adverse event human blood product . Subject clinically significant abnormal finding ( e.g. , laboratory result ECG ) . Subject know Human Immunodeficiency Virus / Acquired Immunodeficiency Syndrome ( HIV/AIDS ) , Hepatitis B C viral infection , acute chronic liver disease . Subject ever cellulitis low extremity , superficial deep vein thrombosis , family history clot disorder . Subject receive investigational device product within 30 day Visit l. Subject receive oral inject anticoagulant . Subject ever abuse drug alcohol ( selfreported ) .</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>